These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30238427)

  • 1. PAXX Participates in Base Excision Repair via Interacting with Pol β and Contributes to TMZ Resistance in Glioma Cells.
    Yang B; Fu X; Hao J; Sun J; Li Z; Li H; Xu H
    J Mol Neurosci; 2018 Oct; 66(2):214-221. PubMed ID: 30238427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficiency of XLF and PAXX prevents DNA double-strand break repair by non-homologous end joining in lymphocytes.
    Hung PJ; Chen BR; George R; Liberman C; Morales AJ; Colon-Ortiz P; Tyler JK; Sleckman BP; Bredemeyer AL
    Cell Cycle; 2017 Feb; 16(3):286-295. PubMed ID: 27830975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAXX and XLF DNA repair factors are functionally redundant in joining DNA breaks in a G1-arrested progenitor B-cell line.
    Kumar V; Alt FW; Frock RL
    Proc Natl Acad Sci U S A; 2016 Sep; 113(38):10619-24. PubMed ID: 27601633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CtIP contributes to non-homologous end joining formation through interacting with ligase IV and promotion of TMZ resistance in glioma cells.
    Yang B; Han N; Sun J; Jiang H; Xu HY
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2092-2102. PubMed ID: 30915754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAXX Is an Accessory c-NHEJ Factor that Associates with Ku70 and Has Overlapping Functions with XLF.
    Tadi SK; Tellier-Lebègue C; Nemoz C; Drevet P; Audebert S; Roy S; Meek K; Charbonnier JB; Modesti M
    Cell Rep; 2016 Oct; 17(2):541-555. PubMed ID: 27705800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA repair. PAXX, a paralog of XRCC4 and XLF, interacts with Ku to promote DNA double-strand break repair.
    Ochi T; Blackford AN; Coates J; Jhujh S; Mehmood S; Tamura N; Travers J; Wu Q; Draviam VM; Robinson CV; Blundell TL; Jackson SP
    Science; 2015 Jan; 347(6218):185-188. PubMed ID: 25574025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactome analysis identifies a new paralogue of XRCC4 in non-homologous end joining DNA repair pathway.
    Xing M; Yang M; Huo W; Feng F; Wei L; Jiang W; Ning S; Yan Z; Li W; Wang Q; Hou M; Dong C; Guo R; Gao G; Ji J; Zha S; Lan L; Liang H; Xu D
    Nat Commun; 2015 Feb; 6():6233. PubMed ID: 25670504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PAXX promotes KU accumulation at DNA breaks and is essential for end-joining in XLF-deficient mice.
    Liu X; Shao Z; Jiang W; Lee BJ; Zha S
    Nat Commun; 2017 Jan; 8():13816. PubMed ID: 28051062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific Roles of XRCC4 Paralogs PAXX and XLF during V(D)J Recombination.
    Lescale C; Lenden Hasse H; Blackford AN; Balmus G; Bianchi JJ; Yu W; Bacoccina L; Jarade A; Clouin C; Sivapalan R; Reina-San-Martin B; Jackson SP; Deriano L
    Cell Rep; 2016 Sep; 16(11):2967-2979. PubMed ID: 27601299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plant PAXX has an XLF-like function and stimulates DNA end joining by the Ku-DNA ligase IV/XRCC4 complex.
    Khan H; Ochi T
    Plant J; 2023 Oct; 116(1):58-68. PubMed ID: 37340932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robust DNA repair in PAXX-deficient mammalian cells.
    Dewan A; Xing M; Lundbæk MB; Gago-Fuentes R; Beck C; Aas PA; Liabakk NB; Sæterstad S; Chau KTP; Kavli BM; Oksenych V
    FEBS Open Bio; 2018 Mar; 8(3):442-448. PubMed ID: 29511621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-Homologous End Joining Factors XLF, PAXX and DNA-PKcs Maintain the Neural Stem and Progenitor Cell Population.
    Gago-Fuentes R; Oksenych V
    Biomolecules; 2020 Dec; 11(1):. PubMed ID: 33379193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAXX and its paralogs synergistically direct DNA polymerase λ activity in DNA repair.
    Craxton A; Munnur D; Jukes-Jones R; Skalka G; Langlais C; Cain K; Malewicz M
    Nat Commun; 2018 Sep; 9(1):3877. PubMed ID: 30250067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An
    Musilli S; Abramowski V; Roch B; de Villartay JP
    J Biol Chem; 2020 Feb; 295(8):2398-2406. PubMed ID: 31915249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leaky severe combined immunodeficiency in mice lacking non-homologous end joining factors XLF and MRI.
    Castañeda-Zegarra S; Zhang Q; Alirezaylavasani A; Fernandez-Berrocal M; Yao R; Oksenych V
    Aging (Albany NY); 2020 Dec; 12(23):23578-23597. PubMed ID: 33289702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonhomologous end joining: new accessory factors fine tune the machinery.
    Ghosh D; Raghavan SC
    Trends Genet; 2021 Jun; 37(6):582-599. PubMed ID: 33785198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrin αVβ3 silencing sensitizes malignant glioma cells to temozolomide by suppression of homologous recombination repair.
    Christmann M; Diesler K; Majhen D; Steigerwald C; Berte N; Freund H; Stojanović N; Kaina B; Osmak M; Ambriović-Ristov A; Tomicic MT
    Oncotarget; 2017 Apr; 8(17):27754-27771. PubMed ID: 27487141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAXX is a novel target to overcome resistance to doxorubicin and cisplatin in osteosarcoma.
    Ma W; Yang L; Liu H; Chen P; Ren H; Ren P
    Biochem Biophys Res Commun; 2020 Jan; 521(1):204-211. PubMed ID: 31640855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction Of XLF And 53BP1 Expression Is Associated With Temozolomide Resistance In Glioblastoma Cells.
    Zhang T; Chai J; Chi L
    Onco Targets Ther; 2019; 12():10139-10151. PubMed ID: 31819508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. XLF-mediated NHEJ activity in hepatocellular carcinoma therapy resistance.
    Yang S; Wang XQ
    BMC Cancer; 2017 May; 17(1):344. PubMed ID: 28526069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.